SEC Filings | Madrigal Pharmaceuticals.

Filing date	Form	Description	View
May 14, 2014	EFFECT	EFFECT	9999999995-14-001452.pdf 9999999995-14-001452.rtf
October 16, 2015	EFFECT	EFFECT	9999999995-15-002773.pdf 9999999995-15-002773.rtf
July 25, 2017	EFFECT	EFFECT	9999999995-17-001915.pdf 9999999995-17-001915.rtf 9999999995-17-001915.xls
February 06, 2007	FWP	FWP	0001047469-07-000662.pdf 0001047469-07-000662.rtf 0001047469-07-000662.xls
March 17, 2009	NT 10-K	Notification that form 10-K will be submitted late	0001104659-09-018029.pdf 0001104659-09-018029.rtf 0001104659-09-018029.xls
February 06, 2007	POS AM	Post-effective amendment to an S-Type filing	0001047469-07-000659.pdf 0001047469-07-000659.rtf 0001047469-07-000659.xls
May 08, 2014	POS AM	Post-effective amendment to an S-Type filing	0001104659-14-036480.pdf 0001104659-14-036480.rtf 0001104659-14-036480.xls
April 17, 2013	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001047469-13-004491.pdf 0001047469-13-004491.rtf 0001047469-13-004491.xls
April 21, 2023	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001193125-23-110261.pdf 0001193125-23-110261.rtf 0001193125-23-110261.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 19, 2016	PREM14A	A preliminary proxy statement relating to a merger or acquisition	0001047469-16-013282.pdf 0001047469-16-013282.rtf 0001047469-16-013282.xls

Data provided by Kaleidoscope.